Co-Delivery of Dihydroartemisinin and Indocyanine Green by Metal-Organic Framework-Based Vehicles for Combination Treatment of Hepatic Carcinoma
Dihydroartemisinin (DHA), a widely used antimalarial agent, has clinical potential for the treatment of hepatic carcinoma. Although chemotherapy is indispensable for tumor therapy, it is generally limited by poor solubility, low efficiency, rapid clearance, and side effects. As an emerging treatment...
Saved in:
Main Authors: | Yang Chen (Author), Bin Wang (Author), Wenping Chen (Author), Tao Wang (Author), Min Li (Author), Zucheng Shen (Author), Fang Wang (Author), Jing Jia (Author), Fenglan Li (Author), Xiangyu Huang (Author), Junyang Zhuang (Author), Ning Li (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical application of indocyanine green fluorescence imaging navigation for pediatric renal cancer
by: Jun Feng, et al.
Published: (2023) -
Silk fibroin nanoparticles dyeing indocyanine green for imaging-guided photo-thermal therapy of glioblastoma
by: He-Lin Xu, et al.
Published: (2018) -
Indocyanine Green Fluorescence-Guided Laparoscopic Ureterolysis for Complex Gynecological Surgeries
by: Ya'nan Yan, et al.
Published: (2023) -
Metal Organic Frameworks as Drug Targeting Delivery Vehicles in the Treatment of Cancer
by: Mengru Cai, et al.
Published: (2020) -
Indocyanine green fluorescence during pediatric stoma closure
by: Keigo Yada, et al.
Published: (2020)